港股異動丨沛嘉醫療-B升超5%創逾一年半新高 年內股價逼近翻倍!
沛嘉醫療-B(9996.HK)午後進一步上揚,一度升5.43%至7.76港元,股價創去年1月3日以來逾一年半新高,年內已累升約95%,市值重回50億港元上方。沛嘉醫療公吿,公司已成功完成MonarQTTVR®系統全球臨牀研究的首名患者植入。此手術由美國加州洛杉磯西達賽奈醫院斯密特心臟研究所副所長兼介入性心臟科主任Raj Makkar醫生及其團隊執行。首名患者植入的成功完成標誌着全球臨牀研究的正式啟動,是公司三尖瓣返流管線開發的一個重要里程碑。(格隆匯)

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.